A Director at Xoma Corp (NASDAQ: XOMA) is Buying Shares

By Carrie Williams

Today, a Director at Xoma Corp (XOMAResearch Report), Denman Van-Ness, bought shares of XOMA for $10.4K.

Following this transaction Denman Van-Ness’ holding in the company was increased by 8.63% to a total of $114.3K. In addition to Denman Van-Ness, 7 other XOMA executives reported Buy trades in the last month.

See today’s analyst top recommended stocks >>

The Company has a Price to Book ratio of 82.4907. Currently, Xoma Corp has an average volume of 174.6K.

The insider sentiment on Xoma Corp has been positive according to 11 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

XOMA Corp. engages in the discovery and development of innovative therapeutics derived from unique platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Berkeley, CA.